首页 > 最新文献

Molecular biology international最新文献

英文 中文
DNA in 3R: Repair, Replication, and Recombination. 3R中的DNA:修复、复制和重组。
Pub Date : 2012-01-01 Epub Date: 2012-03-28 DOI: 10.1155/2012/658579
Frédéric Coin, Bernardo Reina-San-Martin, Giuseppina Giglia-Mari, Mark Berneburg
This special issue entitled “DNA in 3R: Repair, Replication, and Recombination” is dedicated to biological processes that preserve the integrity of our genome. These phenomena have attracted broad interest among a large community of scientists that cross disciplines from mathematics, physics, chemistry, and biology to clinical scientists. DNA is continuously exposed to a range of damaging agents, including reactive cellular metabolites, environmental chemicals, ionizing radiation, and UV light. The biochemical consequences of DNA lesions are diverse and range from obstruction of fundamental cellular pathways like transcription and replication to fixation of mutations. Cellular misfunctioning, cell death, aging, and cancer are the phenotypical consequences of DNA damages accumulation in the genome. Fortunately, an intricate set of genome surveillance mechanisms function to counteract genomic insults. Among these mechanisms, base excision repair and nucleotide excision repair are both dedicated to the removal of single-strand lesions contrary to double-strand break repair. Additionally, some specialized polymerases can temporarily take over lesion-arrested DNA polymerases during S-phase, in a mutagenic mechanism called translesion synthesis. Such polymerases only work if a more reliable system, such as homologous recombination, cannot avoid stumbled DNA replication. These DNA repair mechanisms function in conjunction with an intricate machinery of damage sensors, responsible of a series of phosphorylations and chromatin modifications that signal to the rest of the cell the presence of lesions on the DNA. Together DNA repair mechanisms and DNA damage signaling systems form a molecular shield against genomic instability called DNA Damage Response system. Hence, we have tried to integrate several papers that present a synergy that emerge when researchers from different fields put their forces together into a common goal, trying to improve human health. We thank the contributors for their work and the many reviewers who served conscientiously and tirelessly to assure an issue that meets the standards. Frederic Coin Bernardo Reina-San-Martin Giuseppina Giglia-Mari Mark Berneburg
{"title":"DNA in 3R: Repair, Replication, and Recombination.","authors":"Frédéric Coin, Bernardo Reina-San-Martin, Giuseppina Giglia-Mari, Mark Berneburg","doi":"10.1155/2012/658579","DOIUrl":"https://doi.org/10.1155/2012/658579","url":null,"abstract":"This special issue entitled “DNA in 3R: Repair, Replication, and Recombination” is dedicated to biological processes that preserve the integrity of our genome. These phenomena have attracted broad interest among a large community of scientists that cross disciplines from mathematics, physics, chemistry, and biology to clinical scientists. DNA is continuously exposed to a range of damaging agents, including reactive cellular metabolites, environmental chemicals, ionizing radiation, and UV light. The biochemical consequences of DNA lesions are diverse and range from obstruction of fundamental cellular pathways like transcription and replication to fixation of mutations. Cellular misfunctioning, cell death, aging, and cancer are the phenotypical consequences of DNA damages accumulation in the genome. Fortunately, an intricate set of genome surveillance mechanisms function to counteract genomic insults. Among these mechanisms, base excision repair and nucleotide excision repair are both dedicated to the removal of single-strand lesions contrary to double-strand break repair. Additionally, some specialized polymerases can temporarily take over lesion-arrested DNA polymerases during S-phase, in a mutagenic mechanism called translesion synthesis. Such polymerases only work if a more reliable system, such as homologous recombination, cannot avoid stumbled DNA replication. These DNA repair mechanisms function in conjunction with an intricate machinery of damage sensors, responsible of a series of phosphorylations and chromatin modifications that signal to the rest of the cell the presence of lesions on the DNA. Together DNA repair mechanisms and DNA damage signaling systems form a molecular shield against genomic instability called DNA Damage Response system. Hence, we have tried to integrate several papers that present a synergy that emerge when researchers from different fields put their forces together into a common goal, trying to improve human health. We thank the contributors for their work and the many reviewers who served conscientiously and tirelessly to assure an issue that meets the standards. \u0000 \u0000 \u0000Frederic Coin \u0000 \u0000Bernardo Reina-San-Martin \u0000 \u0000Giuseppina Giglia-Mari \u0000 \u0000Mark Berneburg","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":" ","pages":"658579"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/658579","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40191932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
ASGR1 and ASGR2, the Genes that Encode the Asialoglycoprotein Receptor (Ashwell Receptor), Are Expressed in Peripheral Blood Monocytes and Show Interindividual Differences in Transcript Profile. 编码亚洲糖蛋白受体(Ashwell受体)的基因ASGR1和ASGR2在外周血单核细胞中表达,并在转录谱上表现出个体差异。
Pub Date : 2012-01-01 Epub Date: 2012-08-02 DOI: 10.1155/2012/283974
Rebecca Louise Harris, Carmen Wilma van den Berg, Derrick John Bowen

Background. The asialoglycoprotein receptor (ASGPR) is a hepatic receptor that mediates removal of potentially hazardous glycoconjugates from blood in health and disease. The receptor comprises two proteins, asialoglycoprotein receptor 1 and 2 (ASGR1 and ASGR2), encoded by the genes ASGR1 and ASGR2. Design and Methods. Using reverse transcription amplification (RT-PCR), expression of ASGR1 and ASGR2 was investigated in human peripheral blood monocytes. Results. Monocytes were found to express ASGR1 and ASGR2 transcripts. Correctly spliced transcript variants encoding different isoforms of ASGR1 and ASGR2 were present in monocytes. The profile of transcript variants from both ASGR1 and ASGR2 differed among individuals. Transcript expression levels were compared with the hepatocyte cell line HepG2 which produces high levels of ASGPR. Monocyte transcripts were 4 to 6 orders of magnitude less than in HepG2 but nonetheless readily detectable using standard RT-PCR. The monocyte cell line THP1 gave similar results to monocytes harvested from peripheral blood, indicating it may provide a suitable model system for studying ASGPR function in this cell type. Conclusions. Monocytes transcribe and correctly process transcripts encoding the constituent proteins of the ASGPR. Monocytes may therefore represent a mobile pool of the receptor, capable of reaching sites remote from the liver.

背景。asialal糖蛋白受体(ASGPR)是一种肝脏受体,在健康和疾病中介导血液中潜在危险糖缀合物的清除。该受体包括两种蛋白,asialal糖蛋白受体1和2 (ASGR1和ASGR2),由基因ASGR1和ASGR2编码。设计和方法。应用逆转录扩增技术(RT-PCR)研究了ASGR1和ASGR2在人外周血单核细胞中的表达。结果。单核细胞表达ASGR1和ASGR2转录物。在单核细胞中存在编码ASGR1和ASGR2不同亚型的正确剪接的转录物变体。来自ASGR1和ASGR2的转录本变体在个体之间存在差异。将转录物表达水平与产生高水平ASGPR的肝细胞系HepG2进行比较。单核细胞转录物比HepG2少4到6个数量级,但仍然很容易用标准RT-PCR检测到。单核细胞细胞系THP1与外周血单核细胞的结果相似,表明它可能为研究这种细胞类型的ASGPR功能提供了合适的模型系统。结论。单核细胞转录并正确处理编码ASGPR组成蛋白的转录本。因此,单核细胞可能代表一个受体的移动库,能够到达远离肝脏的部位。
{"title":"ASGR1 and ASGR2, the Genes that Encode the Asialoglycoprotein Receptor (Ashwell Receptor), Are Expressed in Peripheral Blood Monocytes and Show Interindividual Differences in Transcript Profile.","authors":"Rebecca Louise Harris,&nbsp;Carmen Wilma van den Berg,&nbsp;Derrick John Bowen","doi":"10.1155/2012/283974","DOIUrl":"https://doi.org/10.1155/2012/283974","url":null,"abstract":"<p><p>Background. The asialoglycoprotein receptor (ASGPR) is a hepatic receptor that mediates removal of potentially hazardous glycoconjugates from blood in health and disease. The receptor comprises two proteins, asialoglycoprotein receptor 1 and 2 (ASGR1 and ASGR2), encoded by the genes ASGR1 and ASGR2. Design and Methods. Using reverse transcription amplification (RT-PCR), expression of ASGR1 and ASGR2 was investigated in human peripheral blood monocytes. Results. Monocytes were found to express ASGR1 and ASGR2 transcripts. Correctly spliced transcript variants encoding different isoforms of ASGR1 and ASGR2 were present in monocytes. The profile of transcript variants from both ASGR1 and ASGR2 differed among individuals. Transcript expression levels were compared with the hepatocyte cell line HepG2 which produces high levels of ASGPR. Monocyte transcripts were 4 to 6 orders of magnitude less than in HepG2 but nonetheless readily detectable using standard RT-PCR. The monocyte cell line THP1 gave similar results to monocytes harvested from peripheral blood, indicating it may provide a suitable model system for studying ASGPR function in this cell type. Conclusions. Monocytes transcribe and correctly process transcripts encoding the constituent proteins of the ASGPR. Monocytes may therefore represent a mobile pool of the receptor, capable of reaching sites remote from the liver.</p>","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":"2012 ","pages":"283974"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/283974","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30856280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 51
Cellular cofactors of lentiviral integrase: from target validation to drug discovery. 慢病毒整合酶的细胞辅助因子:从靶标验证到药物发现。
Pub Date : 2012-01-01 Epub Date: 2012-08-07 DOI: 10.1155/2012/863405
Oliver Taltynov, Belete A Desimmie, Jonas Demeulemeester, Frauke Christ, Zeger Debyser

To accomplish their life cycle, lentiviruses make use of host proteins, the so-called cellular cofactors. Interactions between host cell and viral proteins during early stages of lentiviral infection provide attractive new antiviral targets. The insertion of lentiviral cDNA in a host cell chromosome is a step of no return in the replication cycle, after which the host cell becomes a permanent carrier of the viral genome and a producer of lentiviral progeny. Integration is carried out by integrase (IN), an enzyme playing also an important role during nuclear import. Plenty of cellular cofactors of HIV-1 IN have been proposed. To date, the lens epithelium-derived growth factor (LEDGF/p75) is the best studied cofactor of HIV-1 IN. Moreover, small molecules that block the LEDGF/p75-IN interaction have recently been developed for the treatment of HIV infection. The nuclear import factor transportin-SR2 (TRN-SR2) has been proposed as another interactor of HIV IN-mediating nuclear import of the virus. Using both proteins as examples, we will describe approaches to be taken to identify and validate novel cofactors as new antiviral targets. Finally, we will highlight recent advances in the design and the development of small-molecule inhibitors binding to the LEDGF/p75-binding pocket in IN (LEDGINs).

为了完成它们的生命周期,慢病毒利用宿主蛋白质,即所谓的细胞辅助因子。在慢病毒感染的早期阶段,宿主细胞和病毒蛋白之间的相互作用提供了有吸引力的新的抗病毒靶点。慢病毒cDNA插入宿主细胞染色体是复制周期中不可逆的一步,此后宿主细胞成为病毒基因组的永久载体和慢病毒子代的生产者。整合是由整合酶(IN)完成的,这种酶在核输入过程中也起着重要作用。许多HIV-1 IN的细胞辅助因子已经被提出。到目前为止,晶状体上皮衍生生长因子(LEDGF/p75)是HIV-1 IN研究最多的辅助因子。此外,阻断LEDGF/p75-IN相互作用的小分子最近被开发用于治疗HIV感染。核输入因子转运蛋白- sr2 (TRN-SR2)被认为是HIV - in介导病毒核输入的另一个相互作用物。以这两种蛋白质为例,我们将描述用于识别和验证作为新的抗病毒靶点的新辅因子的方法。最后,我们将重点介绍结合LEDGF/p75结合口袋in in in (LEDGINs)的小分子抑制剂的设计和开发的最新进展。
{"title":"Cellular cofactors of lentiviral integrase: from target validation to drug discovery.","authors":"Oliver Taltynov,&nbsp;Belete A Desimmie,&nbsp;Jonas Demeulemeester,&nbsp;Frauke Christ,&nbsp;Zeger Debyser","doi":"10.1155/2012/863405","DOIUrl":"https://doi.org/10.1155/2012/863405","url":null,"abstract":"<p><p>To accomplish their life cycle, lentiviruses make use of host proteins, the so-called cellular cofactors. Interactions between host cell and viral proteins during early stages of lentiviral infection provide attractive new antiviral targets. The insertion of lentiviral cDNA in a host cell chromosome is a step of no return in the replication cycle, after which the host cell becomes a permanent carrier of the viral genome and a producer of lentiviral progeny. Integration is carried out by integrase (IN), an enzyme playing also an important role during nuclear import. Plenty of cellular cofactors of HIV-1 IN have been proposed. To date, the lens epithelium-derived growth factor (LEDGF/p75) is the best studied cofactor of HIV-1 IN. Moreover, small molecules that block the LEDGF/p75-IN interaction have recently been developed for the treatment of HIV infection. The nuclear import factor transportin-SR2 (TRN-SR2) has been proposed as another interactor of HIV IN-mediating nuclear import of the virus. Using both proteins as examples, we will describe approaches to be taken to identify and validate novel cofactors as new antiviral targets. Finally, we will highlight recent advances in the design and the development of small-molecule inhibitors binding to the LEDGF/p75-binding pocket in IN (LEDGINs).</p>","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":"2012 ","pages":"863405"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/863405","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30863785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer. 联合RASSF1A和RASSF2A启动子甲基化分析作为膀胱癌诊断的生物标志物。
Pub Date : 2012-01-01 Epub Date: 2012-03-11 DOI: 10.1155/2012/701814
Wei Meng, Alexander Huebner, Ahmad Shabsigh, Arnab Chakravarti, Tim Lautenschlaeger

Promoter hypermethylation, a widely studied epigenetic event known to influence gene expression levels, has been proposed as a potential biomarker in multiple types of cancer. Clinical diagnostic biomarkers are needed for reliable prediction of bladder cancer recurrence. In this paper, DNA promoter methylation of five C-terminal Ras-association family members (RASSF1A, RASSF2A, RASSF4, RASSF5, and RASSF6) was studied in 64 formalin-fixed paraffin-embedded (FFPE) bladder cancer and normal adjacent tissues using methylation-specific high-resolution melting (MS-HRM) analysis. Results showed that 73% (30/41) of transitional cell carcinoma, 100% (3/3) of squamous cell carcinoma, and 100% (4/4) of small cell carcinoma demonstrated promoter methylation of the RASSF1A or RASSF2A gene, but only 6% (1/16) of normal tissues had promoter methylation of RASSF genes. Testing positive for hypermethylation of RASSF1A or RASSF2A promoter provided 77% sensitivity and 94% specificity for identification of cancer tissues with an area under the curve of 0.854, suggesting that promoter methylation analysis of RASSF1A and RASSF2A genes has potential for use as a recurrence biomarker for bladder cancer patients.

启动子超甲基化是一种被广泛研究的表观遗传事件,已知影响基因表达水平,已被提出作为多种类型癌症的潜在生物标志物。临床诊断生物标志物是膀胱癌复发可靠预测的必要条件。本文采用甲基化特异性高分辨率熔融(MS-HRM)分析方法,研究了64例福尔马林固定石蜡包埋(FFPE)膀胱癌和正常癌旁组织中5个ras -关联家族c端成员(RASSF1A、RASSF2A、RASSF4、RASSF5和RASSF6)的DNA启动子甲基化。结果显示,73%(30/41)的移行细胞癌、100%(3/3)的鳞状细胞癌和100%(4/4)的小细胞癌的RASSF1A或RASSF2A基因启动子甲基化,而正常组织中只有6%(1/16)的RASSF基因启动子甲基化。RASSF1A或RASSF2A启动子超甲基化检测阳性,为肿瘤组织鉴定提供了77%的敏感性和94%的特异性,曲线下面积为0.854,这表明RASSF1A和RASSF2A基因启动子甲基化分析有可能作为膀胱癌患者复发的生物标志物。
{"title":"Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer.","authors":"Wei Meng,&nbsp;Alexander Huebner,&nbsp;Ahmad Shabsigh,&nbsp;Arnab Chakravarti,&nbsp;Tim Lautenschlaeger","doi":"10.1155/2012/701814","DOIUrl":"https://doi.org/10.1155/2012/701814","url":null,"abstract":"<p><p>Promoter hypermethylation, a widely studied epigenetic event known to influence gene expression levels, has been proposed as a potential biomarker in multiple types of cancer. Clinical diagnostic biomarkers are needed for reliable prediction of bladder cancer recurrence. In this paper, DNA promoter methylation of five C-terminal Ras-association family members (RASSF1A, RASSF2A, RASSF4, RASSF5, and RASSF6) was studied in 64 formalin-fixed paraffin-embedded (FFPE) bladder cancer and normal adjacent tissues using methylation-specific high-resolution melting (MS-HRM) analysis. Results showed that 73% (30/41) of transitional cell carcinoma, 100% (3/3) of squamous cell carcinoma, and 100% (4/4) of small cell carcinoma demonstrated promoter methylation of the RASSF1A or RASSF2A gene, but only 6% (1/16) of normal tissues had promoter methylation of RASSF genes. Testing positive for hypermethylation of RASSF1A or RASSF2A promoter provided 77% sensitivity and 94% specificity for identification of cancer tissues with an area under the curve of 0.854, suggesting that promoter methylation analysis of RASSF1A and RASSF2A genes has potential for use as a recurrence biomarker for bladder cancer patients.</p>","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":" ","pages":"701814"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/701814","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40180716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma. 人肝细胞癌中RASSF蛋白失活的发病及预后意义。
Pub Date : 2012-01-01 Epub Date: 2012-04-02 DOI: 10.1155/2012/849874
Diego F Calvisi, Matthias Evert, Frank Dombrowski

Hepatocellular carcinoma (HCC) is one of the most frequent solid tumors worldwide, with limited treatment options and a dismal prognosis. Thus, there is a strong need to expand the basic and translational research on this deadly disease in order to improve the prognosis of HCC patients. Although the etiologic factors responsible for HCC development have been identified, the molecular pathogenesis of liver cancer remains poorly understood. Recent evidence has shown the frequent downregulation of Ras association domain family (RASSF) proteins both in the early and late stages of hepatocarcinogenesis. Here, we summarize the data available on the pathogenetic role of inactivation of RASSF proteins in liver cancer, the molecular mechanisms responsible for suppression of RASSF proteins in HCC, and the possible clinical implications arising from these discoveries. Altogether, the data indicate that inactivation of the RASSF1A tumor suppressor is ubiquitous in human liver cancer, while downregulation of RASSF2 and RASSF5 proteins is limited to specific HCC subsets. Also, the present findings speak in favour of therapeutic strategies aimed at reexpressing RASSF1A, RASSF2, and RASSF5 genes and/or inactivating the RASSF cellular inhibitors for the treatment of human liver cancer.

肝细胞癌(HCC)是世界范围内最常见的实体肿瘤之一,治疗选择有限,预后不佳。因此,迫切需要扩大对这一致命疾病的基础和转化研究,以改善HCC患者的预后。虽然已经确定了HCC发生的病因,但对肝癌的分子发病机制仍然知之甚少。最近的证据表明,在肝癌发生的早期和晚期,Ras关联结构域家族(RASSF)蛋白经常下调。在这里,我们总结了RASSF蛋白失活在肝癌中的病理作用,HCC中RASSF蛋白抑制的分子机制,以及这些发现可能产生的临床意义。总之,这些数据表明,RASSF1A肿瘤抑制因子失活在人类肝癌中普遍存在,而RASSF2和RASSF5蛋白的下调仅限于特定的HCC亚群。此外,目前的研究结果支持旨在重新表达RASSF1A、RASSF2和RASSF5基因和/或使RASSF细胞抑制剂失活的治疗策略,以治疗人类肝癌。
{"title":"Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma.","authors":"Diego F Calvisi,&nbsp;Matthias Evert,&nbsp;Frank Dombrowski","doi":"10.1155/2012/849874","DOIUrl":"https://doi.org/10.1155/2012/849874","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is one of the most frequent solid tumors worldwide, with limited treatment options and a dismal prognosis. Thus, there is a strong need to expand the basic and translational research on this deadly disease in order to improve the prognosis of HCC patients. Although the etiologic factors responsible for HCC development have been identified, the molecular pathogenesis of liver cancer remains poorly understood. Recent evidence has shown the frequent downregulation of Ras association domain family (RASSF) proteins both in the early and late stages of hepatocarcinogenesis. Here, we summarize the data available on the pathogenetic role of inactivation of RASSF proteins in liver cancer, the molecular mechanisms responsible for suppression of RASSF proteins in HCC, and the possible clinical implications arising from these discoveries. Altogether, the data indicate that inactivation of the RASSF1A tumor suppressor is ubiquitous in human liver cancer, while downregulation of RASSF2 and RASSF5 proteins is limited to specific HCC subsets. Also, the present findings speak in favour of therapeutic strategies aimed at reexpressing RASSF1A, RASSF2, and RASSF5 genes and/or inactivating the RASSF cellular inhibitors for the treatment of human liver cancer.</p>","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":" ","pages":"849874"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/849874","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40196399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
RASSF Family Proteins. RASSF家族蛋白。
Pub Date : 2012-01-01 Epub Date: 2012-12-10 DOI: 10.1155/2012/938916
Geoffrey J Clark, Shairaz Baksh, Farida Latif, Dae-Sik Lim
1 JG Brown Cancer Center, University of Louisville, 417 CTR Building, 505 S. Hancock Street, Louisville, KY 40202, USA 2Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, 3-055 Katz Group Centre for Pharmacy and Health Research, 113 Street 87 Avenue, Edmonton, AB, Canada T6G 2E1 3School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK 4National Creative Research Initiatives Center for Cell Division and Differentiation, Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 373-1 Guseoung-D, Yuseong-G, Daejeon 305-701, Republic of Korea
{"title":"RASSF Family Proteins.","authors":"Geoffrey J Clark,&nbsp;Shairaz Baksh,&nbsp;Farida Latif,&nbsp;Dae-Sik Lim","doi":"10.1155/2012/938916","DOIUrl":"https://doi.org/10.1155/2012/938916","url":null,"abstract":"1 JG Brown Cancer Center, University of Louisville, 417 CTR Building, 505 S. Hancock Street, Louisville, KY 40202, USA 2Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, 3-055 Katz Group Centre for Pharmacy and Health Research, 113 Street 87 Avenue, Edmonton, AB, Canada T6G 2E1 3School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK 4National Creative Research Initiatives Center for Cell Division and Differentiation, Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 373-1 Guseoung-D, Yuseong-G, Daejeon 305-701, Republic of Korea","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":"2012 ","pages":"938916"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/938916","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31150972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
HIV Assembly and Budding: Ca(2+) Signaling and Non-ESCRT Proteins Set the Stage. HIV组装和出芽:Ca(2+)信号和非escrt蛋白设置阶段。
Pub Date : 2012-01-01 Epub Date: 2012-06-12 DOI: 10.1155/2012/851670
Lorna S Ehrlich, Carol A Carter

More than a decade has elapsed since the link between the endosomal sorting complex required for transport (ESCRT) machinery and HIV-1 protein trafficking and budding was first identified. L domains in HIV-1 Gag mediate recruitment of ESCRT which function in bud abscission releasing the viral particle from the host cell. Beyond virus budding, the ESCRT machinery is also involved in the endocytic pathway, cytokinesis, and autophagy. In the past few years, the number of non-ESCRT host proteins shown to be required in the assembly process has also grown. In this paper, we highlight the role of recently identified cellular factors that link ESCRT machinery to calcium signaling machinery and we suggest that this liaison contributes to setting the stage for productive ESCRT recruitment and mediation of abscission. Parallel paradigms for non-ESCRT roles in virus budding and cytokinesis will be discussed.

自从首次发现运输所需的内体分选复合体(ESCRT)机制与HIV-1蛋白运输和出芽之间的联系以来,已经过去了十多年。HIV-1 Gag中的L结构域介导ESCRT的募集,ESCRT在芽脱落中起作用,将病毒颗粒从宿主细胞中释放出来。除了病毒出芽,ESCRT机制还参与内吞途径、细胞分裂和自噬。在过去的几年中,非escrt宿主蛋白在组装过程中所必需的数量也有所增加。在本文中,我们强调了最近发现的将ESCRT机制与钙信号机制联系起来的细胞因子的作用,我们认为这种联系有助于为ESCRT的有效募集和脱落调解奠定基础。将讨论非escrt在病毒出芽和细胞分裂中的平行作用。
{"title":"HIV Assembly and Budding: Ca(2+) Signaling and Non-ESCRT Proteins Set the Stage.","authors":"Lorna S Ehrlich,&nbsp;Carol A Carter","doi":"10.1155/2012/851670","DOIUrl":"https://doi.org/10.1155/2012/851670","url":null,"abstract":"<p><p>More than a decade has elapsed since the link between the endosomal sorting complex required for transport (ESCRT) machinery and HIV-1 protein trafficking and budding was first identified. L domains in HIV-1 Gag mediate recruitment of ESCRT which function in bud abscission releasing the viral particle from the host cell. Beyond virus budding, the ESCRT machinery is also involved in the endocytic pathway, cytokinesis, and autophagy. In the past few years, the number of non-ESCRT host proteins shown to be required in the assembly process has also grown. In this paper, we highlight the role of recently identified cellular factors that link ESCRT machinery to calcium signaling machinery and we suggest that this liaison contributes to setting the stage for productive ESCRT recruitment and mediation of abscission. Parallel paradigms for non-ESCRT roles in virus budding and cytokinesis will be discussed.</p>","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":"2012 ","pages":"851670"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/851670","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30740167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Retroviral env glycoprotein trafficking and incorporation into virions. 逆转录病毒环境糖蛋白运输和整合到病毒粒子中。
Pub Date : 2012-01-01 Epub Date: 2012-07-02 DOI: 10.1155/2012/682850
Tsutomu Murakami

Together with the Gag protein, the Env glycoprotein is a major retroviral structural protein and is essential for forming infectious virus particles. Env is synthesized, processed, and transported to certain microdomains at the plasma membrane and takes advantage of the same host machinery for its trafficking as that used by cellular glycoproteins. Incorporation of Env into progeny virions is probably mediated by the interaction between Env and Gag, in some cases with the additional involvement of certain host factors. Although several general models have been proposed to explain the incorporation of retroviral Env glycoproteins into virions, the actual mechanism for this process is still unclear, partly because structural data on the Env protein cytoplasmic tail is lacking. This paper presents the current understanding of the synthesis, trafficking, and virion incorporation of retroviral Env proteins.

与Gag蛋白一起,Env糖蛋白是一种主要的逆转录病毒结构蛋白,对形成感染性病毒颗粒至关重要。Env被合成、加工和运输到质膜上的特定微结构域,并利用与细胞糖蛋白相同的宿主机制进行运输。Env并入子代病毒粒子可能是由Env和Gag之间的相互作用介导的,在某些情况下还涉及某些宿主因子。尽管已经提出了几种通用模型来解释逆转录病毒Env糖蛋白与病毒粒子的结合,但这一过程的实际机制仍不清楚,部分原因是缺乏Env蛋白细胞质尾部的结构数据。本文介绍了目前对逆转录病毒Env蛋白的合成、运输和病毒粒子结合的理解。
{"title":"Retroviral env glycoprotein trafficking and incorporation into virions.","authors":"Tsutomu Murakami","doi":"10.1155/2012/682850","DOIUrl":"https://doi.org/10.1155/2012/682850","url":null,"abstract":"<p><p>Together with the Gag protein, the Env glycoprotein is a major retroviral structural protein and is essential for forming infectious virus particles. Env is synthesized, processed, and transported to certain microdomains at the plasma membrane and takes advantage of the same host machinery for its trafficking as that used by cellular glycoproteins. Incorporation of Env into progeny virions is probably mediated by the interaction between Env and Gag, in some cases with the additional involvement of certain host factors. Although several general models have been proposed to explain the incorporation of retroviral Env glycoproteins into virions, the actual mechanism for this process is still unclear, partly because structural data on the Env protein cytoplasmic tail is lacking. This paper presents the current understanding of the synthesis, trafficking, and virion incorporation of retroviral Env proteins.</p>","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":"2012 ","pages":"682850"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/682850","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30774703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Interleukin-1 Two-Locus Haplotype Is Strongly Associated with Severe Chronic Periodontitis among Yemenis. 白介素-1双位点单倍型与也门人重度慢性牙周炎密切相关
Pub Date : 2012-01-01 Epub Date: 2012-06-19 DOI: 10.1155/2012/231309
Nezar Noor Al-Hebshi, Amat-Alrahman Ahmed Shamsan, Mohammed Sultan Al-Ak'hali

Aim. To assess IL-1A C[-889]T and IL-1B C[3954]T genotypes as well as haplotypes in relation to sever chronic periodontitis (SCP) among Yemenis. Materials and Methods. 40 cases with SCP and 40 sex- and age-matched controls were included; all were nonsmokers and free of systemic diseases. Genotyping at each locus was performed using an established PCR-RFLP assay. The Haploview and SimHap software were used to assess data for Hardy-Weinberg's equilibrium (HWE) and linkage disequilibrium (LD) and to obtain subject-level haplotypes. Multiple logistic regression was used to seek for associations in dominant, additive, and recessive models. Results. Mean plaque index (MPI) showed the strongest association with SCP (OR = 16). A significant LD was observed in the cases (D' = 0.80 and r(2) = 0.47). The genotype at each locus showed significant association with SCP in the recessive model (TT versus TC + CC) even after adjustment for MPI (OR = 6.29 & 461, resp.). The C-T haplotype conferred protection against SCP in a dominant manner (OR = 0.16). On the other hand, the T-T haplotype in double dose (recessive model) showed strong association with CP (OR = 15.6). Conclusions. IL-1 two-locus haplotype is associated with SCP in Yemenis. Haplotype-based analysis may be more suited for use in genetic association studies of periodontitis.

目标评估IL-1A C[-889]T和IL-1B C[3954]T基因型以及单倍型与也门人严重慢性牙周炎(SCP)的关系。材料和方法。纳入40例SCP患者和40例性别和年龄匹配的对照组;所有人都不吸烟,没有系统性疾病。使用已建立的PCR-RFLP测定法对每个基因座进行基因分型。Haploview和SimHap软件用于评估Hardy-Weinberg平衡(HWE)和连锁不平衡(LD)的数据,并获得受试者水平的单倍型。多元逻辑回归用于寻找显性、加性和隐性模型中的关联。后果平均斑块指数(MPI)与SCP相关性最强(OR=16)。在这些病例中观察到显著的LD(D’=0.80,r(2)=0.47)。即使在MPI调整后,每个基因座的基因型在隐性模型中也显示出与SCP的显著相关性(TT与TC+CC)(OR分别为6.29和461)。C-T单倍型以显性方式赋予了对SCP的保护作用(OR=0.16)。另一方面,双剂量(隐性模型)T-T单倍型与CP有很强的相关性(OR=15.6)。在也门人中IL-1双基因座单倍型与SCP相关。基于单倍型的分析可能更适合用于牙周炎的遗传关联研究。
{"title":"Interleukin-1 Two-Locus Haplotype Is Strongly Associated with Severe Chronic Periodontitis among Yemenis.","authors":"Nezar Noor Al-Hebshi,&nbsp;Amat-Alrahman Ahmed Shamsan,&nbsp;Mohammed Sultan Al-Ak'hali","doi":"10.1155/2012/231309","DOIUrl":"10.1155/2012/231309","url":null,"abstract":"<p><p>Aim. To assess IL-1A C[-889]T and IL-1B C[3954]T genotypes as well as haplotypes in relation to sever chronic periodontitis (SCP) among Yemenis. Materials and Methods. 40 cases with SCP and 40 sex- and age-matched controls were included; all were nonsmokers and free of systemic diseases. Genotyping at each locus was performed using an established PCR-RFLP assay. The Haploview and SimHap software were used to assess data for Hardy-Weinberg's equilibrium (HWE) and linkage disequilibrium (LD) and to obtain subject-level haplotypes. Multiple logistic regression was used to seek for associations in dominant, additive, and recessive models. Results. Mean plaque index (MPI) showed the strongest association with SCP (OR = 16). A significant LD was observed in the cases (D' = 0.80 and r(2) = 0.47). The genotype at each locus showed significant association with SCP in the recessive model (TT versus TC + CC) even after adjustment for MPI (OR = 6.29 & 461, resp.). The C-T haplotype conferred protection against SCP in a dominant manner (OR = 0.16). On the other hand, the T-T haplotype in double dose (recessive model) showed strong association with CP (OR = 15.6). Conclusions. IL-1 two-locus haplotype is associated with SCP in Yemenis. Haplotype-based analysis may be more suited for use in genetic association studies of periodontitis.</p>","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":"2012 ","pages":"231309"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/231309","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30750241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs. HIV基因多态性和亚型差异对抗逆转录病毒药物耐药发生的影响
Pub Date : 2012-01-01 Epub Date: 2012-06-26 DOI: 10.1155/2012/256982
Mark A Wainberg, Bluma G Brenner
The vast majority of reports on drug resistance deal with subtype B infections in developed countries, and this is largely due to historical delays in access to antiretroviral therapy (ART) on a worldwide basis. This notwithstanding the concept that naturally occurring polymorphisms among different non-B subtypes can affect HIV-1 susceptibility to antiretroviral drugs (ARVs) is supported by both enzymatic and virological data. These findings suggest that such polymorphisms can affect both the magnitude of resistance conferred by some major mutations as well as the propensity to acquire certain resistance mutations, even though such differences are sometimes difficult to demonstrate in phenotypic assays. It is mandatory that tools are optimized to assure accurate measurements of drug susceptibility in non-B subtypes and to recognize that each subtype may have a distinct resistance profile and that differences in resistance pathways may also impact on cross-resistance and the choice of regimens to be used in second-line therapy. Although responsiveness to first-line therapy should not theoretically be affected by considerations of viral subtype and drug resistance, well-designed long-term longitudinal studies involving patients infected by viruses of different subtypes should be carried out.
绝大多数关于耐药性的报告涉及发达国家的B亚型感染,这在很大程度上是由于世界范围内获得抗逆转录病毒治疗(ART)的历史延误。尽管酶学和病毒学数据都支持不同非b亚型之间自然发生的多态性可以影响HIV-1对抗逆转录病毒药物(ARVs)的易感性的概念。这些发现表明,这种多态性既可以影响一些主要突变所赋予的抗性的大小,也可以影响获得某些抗性突变的倾向,尽管这种差异有时难以在表型分析中证明。必须优化工具,以确保准确测量非b亚型的药物敏感性,并认识到每种亚型可能具有不同的耐药谱,耐药途径的差异也可能影响交叉耐药和二线治疗方案的选择。虽然对一线治疗的反应性理论上不应受到病毒亚型和耐药性的影响,但应该进行设计良好的涉及不同亚型病毒感染患者的长期纵向研究。
{"title":"The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.","authors":"Mark A Wainberg,&nbsp;Bluma G Brenner","doi":"10.1155/2012/256982","DOIUrl":"https://doi.org/10.1155/2012/256982","url":null,"abstract":"The vast majority of reports on drug resistance deal with subtype B infections in developed countries, and this is largely due to historical delays in access to antiretroviral therapy (ART) on a worldwide basis. This notwithstanding the concept that naturally occurring polymorphisms among different non-B subtypes can affect HIV-1 susceptibility to antiretroviral drugs (ARVs) is supported by both enzymatic and virological data. These findings suggest that such polymorphisms can affect both the magnitude of resistance conferred by some major mutations as well as the propensity to acquire certain resistance mutations, even though such differences are sometimes difficult to demonstrate in phenotypic assays. It is mandatory that tools are optimized to assure accurate measurements of drug susceptibility in non-B subtypes and to recognize that each subtype may have a distinct resistance profile and that differences in resistance pathways may also impact on cross-resistance and the choice of regimens to be used in second-line therapy. Although responsiveness to first-line therapy should not theoretically be affected by considerations of viral subtype and drug resistance, well-designed long-term longitudinal studies involving patients infected by viruses of different subtypes should be carried out.","PeriodicalId":74217,"journal":{"name":"Molecular biology international","volume":"2012 ","pages":"256982"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/256982","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30760213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 64
期刊
Molecular biology international
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1